Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2026)

Amneal Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $13.4 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 2512.09% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $32.0 million (up 413.11% YoY), while the FY2025 annual figure was $19.2 million, up 1898.23% from the prior year.
• Other Working Capital Changes was $13.4 million for Q1 2026 at Amneal Pharmaceuticals, up from -$1.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $115.3 million in Q2 2022 to a low of -$85.4 million in Q3 2022.
• Historically, Other Working Capital Changes has averaged -$833764.7 across 5 years, with a median of -$1.0 million in 2025.
• The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes plunged 2535.58% in 2022, then jumped 2512.09% in 2026.
• A 5-year view of Other Working Capital Changes shows it stood at -$44.3 million in 2022, then jumped by 70.62% to -$13.0 million in 2023, then jumped by 91.36% to -$1.1 million in 2024, then gained by 10.06% to -$1.0 million in 2025, then soared by 1426.73% to $13.4 million in 2026.
• The last three Other Working Capital Changes figures came in at $13.4 million (Q1 2026), -$1.0 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.